WallStreetZenWallStreetZen

NASDAQ: COLL
Collegium Pharmaceutical Inc Stock Ownership - Who owns Collegium Pharmaceutical?

OverviewForecastEarningsDividendOwnership

Insider buying vs selling

Have Collegium Pharmaceutical Inc insiders been buying or selling?
Buy
Sell
NameRoleDateSharesPriceValue
Thomas B. SmithEVP and Chief Medical Officer2024-02-29995$36.76
$36.58kSell
Scott DreyerEVP Chief Commercial Officer2024-02-269,336$36.38
$339.60kSell
Scott DreyerEVP Chief Commercial Officer2024-02-26664$37.15
$24.67kSell
Thomas B. SmithEVP and Chief Medical Officer2024-02-121,899$33.70
$64.00kSell
Thomas B. SmithEVP and Chief Medical Officer2024-02-121,300$33.70
$43.81kSell
Shirley R. KuhlmannEVP and General Counsel2024-02-1221,146$33.70
$712.62kSell
Shirley R. KuhlmannEVP and General Counsel2024-02-1210,610$33.70
$357.56kSell
Scott DreyerEVP Chief Commercial Officer2024-02-1219,545$33.70
$658.67kSell
Scott DreyerEVP Chief Commercial Officer2024-02-1210,145$33.70
$341.89kSell
Joseph CiaffoniPresident and CEO2024-02-1281,422$33.70
$2.74MSell

1 of 4

COLL insiders have sold more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when COLL insiders and whales buy or sell their stock.

COLL Shareholders

What type of owners hold Collegium Pharmaceutical Inc stock?
Institutional
Insider
Retail
NameHoldSharesValueType
David Hirsch20.15%6,438,798$223.68MInsider
Blackrock Inc18.11%5,786,993$201.04MInstitution
Longitude Capital Partners LLC17.66%5,643,684$196.06MInsider
Skyline Venture Partners V LP15.96%5,099,832$177.17MInsider
Rubric Capital Management LP8.63%2,758,253$95.82MInstitution
Eventide Asset Management LLC8.23%2,630,478$91.38MInstitution
Vanguard Group Inc7.24%2,312,786$80.35MInstitution
Pacer Advisors Inc6.80%2,174,718$75.55MInstitution
Yasunori Kaneko6.73%2,150,186$74.70MInsider
Patrick J. Heron5.91%1,887,332$65.57MInsider

1 of 3

COLL vs Pharmaceutical Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
COLL58.62%41.38%Net SellingNet Selling
DCPH67.11%32.89%Net BuyingNet Buying
PCRX68.56%31.44%Net SellingNet Selling
IRWD72.14%27.86%Net SellingNet Selling
CRON8.71%48.47%Net BuyingNet Selling
View Top Pharmaceutical Stocks

Collegium Pharmaceutical Stock Ownership FAQ

Who owns Collegium Pharmaceutical?

Collegium Pharmaceutical (NASDAQ: COLL) is owned by 122.71% institutional shareholders, 86.62% Collegium Pharmaceutical insiders, and 0.00% retail investors. David Hirsch is the largest individual Collegium Pharmaceutical shareholder, owning 6.44M shares representing 20.15% of the company. David Hirsch's Collegium Pharmaceutical shares are currently valued at $231.41M.

If you're new to stock investing, here's how to buy Collegium Pharmaceutical stock.
©2024 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.